Obstetric Outcomes of Severe COVID-19 Pneumonia in Pregnant Lady After Caesarean Delivery: A Case report: Severe Life-threatening Peripartum Covid Pneumonia

Since the outbreak of coronavirus (COVID-19) in December 2019, understanding regarding coronavirus symptoms has been evolving. Medical issues in pregnancy usually resolve after delivery. Similarly, pregnant ladies with COVID-19 pneumonia had improvement in their condition after giving birth. However...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The international journal of frontier sciences 2024-07, Vol.6 (1)
Hauptverfasser: Kumari, Usha, Manjunath, Keerthana, Hassan, Zair, Abbas, Fakhar
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Since the outbreak of coronavirus (COVID-19) in December 2019, understanding regarding coronavirus symptoms has been evolving. Medical issues in pregnancy usually resolve after delivery. Similarly, pregnant ladies with COVID-19 pneumonia had improvement in their condition after giving birth. However, in this case, the patient tested positive for "SARS-Cov-19 antigen PCR" and intended for vaginal birth, which was unsuccessful and resulted in a caesarean surgery. After the healthy baby was delivered, she experienced a life-threatening cytokine storm that necessitated elective intubation and mechanical breathing, as well as anti-viral medication. She was extubated after two weeks and then discharged on recovery. Previously, the Middle Eastern Respiratory Syndrome Coronavirus (MERS-SARS) and the Influenza virus (H1N1) were the most well-known viruses for generating potentially fatal results in pregnancy. This is first reported instance in Pakistan of a pregnant lady developing severe COVID-19 pneumonia. This research fills a vacuum in the medical literature and alerts obstetricians and clinicians to the likelihood of life-threatening postpartum, COVID-19 pneumonia complications.
ISSN:2618-0359
2618-0367
DOI:10.37978/tijfs.v6i1.389